NCT00561418
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Hodgkin Disease, +22 more
- Locations
-
- Ohio State University Medical Center Columbus, Ohio, United States
Clinical trial condition
Lymphoma, T-Cell
Explore clinical trials studying Lymphoma, T-Cell. Study availability and eligibility vary by location and protocol.
694 public trials
105 recruiting studies
Lymphoma, T-Cell trial results
NCT00431912
- Conditions
- Cutaneous T-Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
- Locations
-
- Department of Dermatology, Medical University Graz Graz, Austria
- Deapartment of Dermatology Créteil, France
- department of Dermatologie, Hotel Dieu Nantes, France
- University Clinic for Dermatology, Medical Faculty of Mannheim of the Heidelberg University Mannheim, Germany
NCT00716911
- Conditions
- Blast Crisis, Blood Protein Disorders, Bone Marrow Diseases, +66 more
- Locations
-
Not specified
NCT00951626
- Conditions
- Blast Crisis, Blood Protein Disorders, Bone Marrow Diseases, +66 more
- Locations
-
- City of Hope Comprehensive Cancer Center Duarte, California, United States
NCT00720135
- Conditions
- Anaplastic Large Cell Lymphoma, Blood Protein Disorders, Cardiovascular Diseases, +35 more
- Locations
-
- City of Hope Duarte, California, United States
NCT00453427
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
- Locations
-
- St. Paul's Hospital Vancouver, British Columbia, Canada
- Juravinski Cancer Centre Hamilton, Ontario, Canada
- London Health Sciences Centre London, Ontario, Canada
- Sunnybrook Health Sciences Centre, Odette Cancer Centre Toronto, Ontario, Canada
NCT00045500
- Conditions
- Burkitt Lymphoma, Chronic Disease, DNA Virus Infections, +40 more
- Locations
-
- Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support Bethesda, Maryland, United States
- NCI - Center for Cancer Research Bethesda, Maryland, United States
- Frederick Cancer Research and Development Center Frederick, Maryland, United States
NCT00060021
- Conditions
- Adnexal Diseases, Blast Crisis, Blood Protein Disorders, +103 more
- Locations
-
- Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support Bethesda, Maryland, United States
Completed
LMB-2 Immunotoxin in Treating Young Patients With Relapsed or Refractory Leukemia or Lymphoma
NCT00085150
- Conditions
- Burkitt Lymphoma, DNA Virus Infections, Dendritic Cell Sarcoma, Interdigitating, +31 more
- Locations
-
- Winship Cancer Institute of Emory University Atlanta, Georgia, United States
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States
- Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office Bethesda, Maryland, United States
- Doernbecher Children's Hospital at Oregon Health & Science University Portland, Oregon, United States
Completed
Bryostatin 1 and Interleukin-2 in Treating Patients With Refractory Solid Tumors or Lymphoma
NCT00003993
- Conditions
- Burkitt Lymphoma, Chronic Disease, DNA Virus Infections, +43 more
- Locations
-
- National Institute on Aging - Baltimore Baltimore, Maryland, United States